What Is Wolverine Blend? BPC-157 + TB-500 Explained
A plain explanation of the nickname, what is actually in the vial, and how to read blend strength labels before buying.
Wolverine Blend is a community nickname commonly used for a combination of BPC-157 and TB-500. The name does not refer to a separate peptide. It generally describes a product that supplies both compounds together, although exact ratios and total strengths can vary between sellers.
This guide explains how the name is used, how to read product-strength labels, and how a combined vial differs from purchasing BPC-157 and TB-500 separately.
Looking for the combined formulation?
What Does Wolverine Blend Mean?
“Wolverine Blend” is an informal name that circulates in peptide research communities, forums and supplier catalogues. It is not a chemical name, a trade name registered to any single manufacturer, or the name of a third compound. It is shorthand for a research formulation that contains two separate peptides in the same vial: BPC-157 and TB-500.
Because the name is informal, it carries no guaranteed specification. Two products sold under the same nickname can contain different amounts of each compound, or different ratios between them. The name tells you which two compounds are involved; it tells you nothing about how much of each is present. That information has to come from the product label and the accompanying documentation, not from the nickname.
The practical consequence is simple: treat “Wolverine Blend” as a search term, then read the composition before comparing one product with another.
What Is in Wolverine Blend?
A Wolverine Blend product contains two research peptides:
- BPC-157, a synthetic peptide sequence studied in preclinical research models.
- TB-500, a synthetic fragment related to thymosin beta-4, also studied in preclinical models.
Both are supplied as lyophilized (freeze-dried) powder. In a blend, the two powders are combined in a single sealed vial rather than supplied as two vials. Nothing is dissolved in advance, so the product is not a ready-to-use liquid.
Research into both compounds is experimental and largely preclinical. Neither compound is an approved medicine, and material sold under this nickname is supplied as a research formulation, not as a treatment.
Wolverine Blend vs. Wolverine Stack
The two terms are used interchangeably in most conversations, but they do not strictly mean the same thing.
| Wolverine Blend | Usually means both compounds are supplied together, premixed as powder, in one vial. |
|---|---|
| Wolverine Stack | May mean the same single combined vial, or may mean two separately supplied products used within the same research design. |
Because the usage overlaps, the safest approach is to ignore which of the two words a listing uses and check the vial configuration instead. A product page should state clearly whether you are receiving one vial containing both compounds or two separate vials.
Understanding 5mg + 5mg and 10mg + 10mg
Blend strengths are written in two different ways, and the difference is a frequent source of confusion.
- Per-compound notation states the amount of each peptide: 5mg BPC-157 + 5mg TB-500.
- Total notation states the combined amount in the vial: 10mg total.
Those two labels describe the same vial. A vial holding 5mg of each compound holds 10mg of peptide in total. A vial holding 10mg of each holds 20mg in total.
| 5mg BPC-157 + 5mg TB-500 | 10mg total in the vial, 1:1 ratio by milligram weight. |
|---|---|
| 10mg BPC-157 + 10mg TB-500 | 20mg total in the vial, 1:1 ratio by milligram weight. |
This matters when comparing sellers. A listing advertised as “10mg” could mean 10mg of each compound (20mg total) or 10mg total split between them (5mg each) — a twofold difference in material for the same headline number. A listing that states only a total, with no breakdown, has not told you enough to make the comparison. Look for a label that gives both figures, as in “5mg BPC-157 + 5mg TB-500 — 10mg total”.
Ratio is the second variable. A 1:1 blend by milligram weight contains equal masses of the two compounds. Some blends are not 1:1; if the ratio is not stated, it has not been specified.
Combined Blend vs. Separate Vials
Neither format is inherently better. They suit different research designs.
A combined vial suits work where the two compounds are always handled together
One vial means one reconstitution step, one solvent volume to calculate, and a fixed ratio that cannot drift between preparations. For a protocol that treats the pair as a single input, that is fewer steps and fewer opportunities for handling error.
Separate vials suit work where the compounds must be varied independently
If a study design needs to change the amount of one compound without changing the other, compare them side by side, or evaluate either on its own, the two compounds have to arrive in separate vials. A premixed blend locks the ratio at the point of manufacture, so that flexibility is gone.
A practical way to decide: if the research plan ever needs one compound without the other, buy them separately. If the plan only ever uses them together in a fixed proportion, a blend removes work.
How to Review Wolverine Blend Product Documentation
Because the nickname guarantees nothing, documentation is what makes one listing verifiable and another one not. Ask for the documentation that corresponds to the lot being shipped, and read it for the following.
- Lot or batch number. It should match the lot on the vial you receive. A report for a different lot describes different material.
- Identity of both compounds. A blend report should confirm BPC-157 and TB-500 separately, not just report a single unnamed peptide.
- Tested purity. Purity belongs to a lot, not to a product line. Treat a purity figure printed in sales copy, with no lot attached, as unverified.
- Test method. The analytical method used, for example HPLC for purity and mass spectrometry for identity.
- Test date. Recent enough to relate to the material currently being shipped.
- Laboratory information. Which laboratory performed the analysis, so the report can be traced.
If documentation is not published on the product page, it is reasonable to request it before ordering. A supplier that cannot connect a report to the lot in stock has not actually documented that lot.
Research Status and Important Limitations
BPC-157 and TB-500 are both experimental compounds. The published work on them is predominantly preclinical, and neither has been approved as a medicine. Material sold under the Wolverine Blend nickname is supplied strictly as a research formulation for laboratory and analytical work.
This guide does not provide dosing information, preparation-for-use instructions, or any protocol for administration, because the material is not intended for human or veterinary use, diagnosis, treatment or therapeutic application. It makes no claim about healing, recovery, pain, tissue repair or injury outcomes. Claims of that kind are not supported for these compounds and are not made here.
Anyone sourcing these materials should also confirm that their intended use complies with the laws and institutional rules that apply to them.
Review available Wolverine Blend BPC-157 + TB-500 strength options.
Frequently Asked Questions
Is Wolverine Blend a single peptide?
No. It is a nickname for two peptides, BPC-157 and TB-500, supplied together. There is no third compound called Wolverine.
Does every Wolverine Blend contain the same amounts?
No. Ratios and total strengths vary between sellers. Read the stated composition rather than relying on the nickname.
Does “10mg” mean 10mg of each compound?
Not necessarily. It may mean 10mg in total, split between the two compounds. A clear label states both the per-compound amounts and the total.
Is a blend cheaper than buying the compounds separately?
That depends on the seller and the strengths compared. Compare on the total milligrams of each compound received, not on the headline number in the product name.
Can a blend be separated back into individual compounds?
Not in ordinary laboratory handling. Once the powders are combined in a vial, the ratio is fixed. Work that needs the compounds independently requires separate products.
This article is general information about terminology and product labelling. All compounds referenced are supplied for laboratory and analytical research only. They are not for human or veterinary use, and they are not intended to diagnose, treat, cure or prevent any condition.
For laboratory and research use only. This article summarizes published scientific literature for informational purposes. It is not intended for human or veterinary use, and nothing here is medical advice or a dosing recommendation.
Research References
- Chang, et al. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of Applied Physiology. 2010. PubMed
- Krivic, et al. Achilles detachment in rat and stable gastric pentadecapeptide BPC 157: Promoted tendon-to-bone healing and opposed corticosteroid aggravation. Journal of Orthopaedic Research. 2006. PubMed
- Malinda, et al. Thymosin beta4 accelerates wound healing. The Journal of Investigative Dermatology. 1999. PubMed
- Goldstein, et al. Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications. Expert Opinion on Biological Therapy. 2011. PubMed
Written by Jay Cipollone, Founder & Research Lead, MyGLP1Store — a veteran-owned, U.S.-based research-peptide supplier with third-party lab testing and published certificates of analysis (COAs).